ARAlessandra Raccichini

Alessandra Raccichini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alessandra Raccichini has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Technology-Assisted Cognitive Support for Older Adults With Mild Cognitive Impairment: Study Protocol for the DHEAL-COM COGNITIVE Quasi-Experimental Pilot Study

    by Roberta Bevilacqua, Elvira Maranesi, Elisa Felici, Rachele Alessandra Marziali, Arianna Margaritini, Arianna Sgolastra, Lucia Paciaroni, Alessandra Raccichini, Giuseppe Pelliccioni, Lucrezia Grassi, et al.

    Background: Mild cognitive impairment (MCI) represents a transitional phase between normal aging and dementia. While no pharmacological treatments have proven effective, nonpharmacological interventions, such as cognitive stimulation and psychosocial support, have shown promise. Integrating digital tools and socially assistive robotics may improve engagement, personalization, and access to care, contributing to the preservation of cognitive function and overall well-being in older adults. Objective: The DHEAL-COM COGNITIVE pilot study aims to evaluate the feasibility, acceptability, and preliminary efficacy of a sociotechnological intervention that combines digital cognitive stimulation, social robot interaction, and group training in digital and health literacy to counteract cognitive decline. Methods: This is a single-blind, quasi-experimental feasibility trial involving 60 older adults with MCI, recruited from the Neurology and Alzheimer Units of IRCCS INRCA (INRCA – IRCCS Istituto Nazionale di Ricovero e Cura per Anziani). Participants were allocated into 2 groups: the experimental group received home-based cognitive training via the Brainer app, a month-long interaction with the NAO social robot, and weekly group sessions on eHealth literacy and cognitive stimulation; the control group received a well-being booklet with optional activities. Assessments were conducted at baseline, postintervention after 12 weeks, and follow-up after 3 months, using validated instruments, such as the Montreal Cognitive Assessment, the EQ-5D-5L, the Italian version of the eHealth Literacy Scale, the System Usability Scale, the unified theory of acceptance and use of technology, and the Psychological Well-Being Scale. Descriptive statistics will be used to summarize feasibility, usability, and acceptability outcomes, while preliminary differences over time will be explored using appropriate inferential analyses, acknowledging that the study is not powered to detect effectiveness. Results: Patient recruitment began in March 2025 and continued through September 2025. As of April 2026, 36 patients have been recruited, with 18 participants per group. The trial started in May 2025 and ran throughout the year. Results will focus on changes in cognitive performance, psychological well-being, quality of life, eHealth literacy, and user acceptability and usability of the technologies. Findings will be analyzed quantitatively and qualitatively and are expected to be published by the end of 2026. Conclusions: The DHEAL-COM COGNITIVE study proposes an innovative, integrated intervention for older adults with MCI, using digital platforms and social robotics to support cognitive health and autonomy. This pilot study represents a promising step toward a more integrated and technology-supported model of care for older adults with MCI.

  • Open Access

    Technology-Assisted Cognitive Support for Older Adults with Mild Cognitive Impairment: Study Protocol for the DHEAL-COM Randomized Pilot Trial (Preprint)

    by Roberta Bevilacqua, Elvira Maranesi, Elisa Felici, Rachele Alessandra Marziali, Arianna Margaritini, Arianna Sgolastra, Lucia Paciaroni, Alessandra Raccichini, Giuseppe Pelliccioni, Lucrezia Grassi, et al.

    BACKGROUND Mild Cognitive Impairment (MCI) represents a transitional phase between normal aging and dementia. While no pharmacological treatments have proven effective, non-pharmacological interventions, such as cognitive stimulation and psychosocial support, have shown promise. Integrating digital tools and social assistive robotics may improve engagement, personalization, and access to care, contributing to the preservation of cognitive function and overall well-being in older adults. OBJECTIVE The DHEAL-COM pilot study aims to evaluate the feasibility, acceptability, and preliminary efficacy of a socio-technological intervention that combines digital cognitive stimulation, social robot interaction, and group training in digital and health literacy to counteract cognitive decline and promote autonomy among older adults with MCI. METHODS This is a single-blind, randomized controlled feasibility trial involving 60 older adults with MCI, recruited from the Neurology and Alzheimer Units of IRCCS INRCA. Participants are randomized into two groups: the experimental group receives home-based cognitive training via the Brainer app, a month-long interaction with the NAO social robot, and weekly group sessions on eHealth and digital literacy; the control group receives a well-being booklet with optional activities. Assessments are conducted at baseline (T0), post-intervention after 12 weeks (T1), and follow-up after 3 months (T2), using validated instruments such as MoCA, EQ-5D-5L, IT-eHEALS, SUS, UTAUT, and PWB. RESULTS Patient recruitment began in March 2025 and will continue through September 2025. The trial started in May 2025 and will run throughout the year. Results will focus on changes in cognitive performance, psychological well-being, quality of life, eHealth literacy, and user acceptability and usability of the technologies. Findings will be analyzed quantitatively and qualitatively and are expected to be published by 2026. CONCLUSIONS The DHEAL-COM study proposes an innovative, integrated intervention for older adults with MCI, using digital platforms and social robotics to support cognitive health and autonomy. This pilot study represents a promising step toward a more integrated and technology-supported model of care for older adults with MCI. CLINICALTRIAL The study protocol was recorded in ClinicalTrials.gov on the number NCT06984367.

  • The 4-DSD: A New Tool to Assess Delirium Superimposed on Moderate to Severe Dementia

    by Alessandro Morandi, Eleonora Grossi, Elena Lucchi, Antonella Zambon, Bianca Faraci, Jessica Severgnini, Alasdair MacLullich, Heidi Smith, Pratik Pandharipande, Andrea Rizzini, et al.


  • Living With Mild to Moderate Alzheimer Patients Increases the Caregiver’s Burden at 6 Months

    by Alessandra Raccichini, Liana Spazzafumo, Simona Castellani, Patrizia Civerchia, Giuseppe Pelliccioni, Osvaldo Scarpino

    The objective of our study was to demonstrate that living with a person affected by mild to moderate Alzheimer’s disease can lead to an increased perception of the caregiver’s burden using the Caregiver Burden Inventory (CBI). The sample consisted of 153 dyads, caregiver–patient. At baseline, a greater perception of the caregiver’s burden was observed in the live-in caregivers. A further increase in the total burden of the live-in caregivers was noticed at the 6-month follow-up. More specifically, with the inclusion of correction factors such as the caregiver’s age and the CBI subscales at baseline, the social and emotional burden becomes statistically significant (P < .001). The present paper confirms our hypothesis that live-in caregivers perceive a greater burden than nonlive-in, and this difference increases further after 6 months. The difference in involvement between live-in and nonlive-in caregivers could be the foundation to tailor more specific interventions.


  • The Caregiver’s Burden of Alzheimer Patients: Differences Between Live-In and Non-Live-In

    by Alessandra Raccichini, Simona Castellani, Patrizia Civerchia, Paola Fioravanti, Osvaldo Scarpino

    The objective of our study was to describe the burden of a sample of 208 live-in/non-live-in caregivers of patients with Alzheimer’s disease (AD). We analyzed the statistical correlation between Caregiver Burden Inventory (CBI) and the live-in/non-live-in caregiver status, and between the ‘‘objective burden,’’ the cognitive deterioration, functional ability, and psychic and behavioral disorders. Using analysis of variance (ANOVA), the live-in groups of caregivers were compared to each subscale and to the total CBI. Living with a patient causes a bigger burden associated to the ‘‘developmental and physical burden,’’ which is affected more by the functional impairment than by the cognitive-behavioral aspect. Understanding the aspects of this burden in the initial-intermediate phase of the disease and being able to monitor it over time could contribute to improving the interventions already in place, which affect burden, stress, and quality of life of caregivers and their sick family members.